Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Specific Immunotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT01014325
What this trial is testing

Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy

Who this might be right for
Allergic Rhinitis
Roxall Medizin 130
Early research (Phase 1)WithdrawnNCT02210104
What this trial is testing

Adoptive Therapy Using Antigen-Specific CD4 T-Cells

Who this might be right for
MelanomaSarcoma
M.D. Anderson Cancer Center
Not applicableNo Longer AvailableNCT00547235
What this trial is testing

Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection

Who this might be right for
InfectionPrecancerous/Nonmalignant Condition
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03559413
What this trial is testing

Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL

Who this might be right for
Primary/Relapsed Acute Lymphoblastic Leukemia (ALL) of Childhood, Adolescents and Young Adults
University Children's Hospital Tuebingen 30
Early research (Phase 1)Study completedNCT00182650
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT02223182
What this trial is testing

Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy

Who this might be right for
Food Allergy
DBV Technologies 198
Early research (Phase 1)Not Yet RecruitingNCT07414979
What this trial is testing

Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal Melanoma

Who this might be right for
Leptomeningeal Melanoma
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Ended earlyNCT02297490
What this trial is testing

Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical Trials

Who this might be right for
Allergic RhinoconjunctivitisHealthy Volunteers
Allergopharma GmbH & Co. KG 158
Testing effectiveness (Phase 2)Ended earlyNCT01948180
What this trial is testing

Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma

Who this might be right for
Lymphoma, Extranodal NK-T-CellEBV
Cell Medica Ltd 15
Early research (Phase 1)Study completedNCT00045149
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00263926
What this trial is testing

Efficacy and Safety of a Purified Standardised Wasp Venom Preparation

Who this might be right for
Allergy
Allergopharma GmbH & Co. KG
Early research (Phase 1)UnknownNCT02140996
What this trial is testing

Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial Cancers

Who this might be right for
Epithelial Cancers of the Lung, Breast, Ovary, Prostate and Colon
Singapore Clinical Research Institute 24
Testing effectiveness (Phase 2)UnknownNCT02632188
What this trial is testing

Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Liver Cancer
Second Military Medical University 60
Testing effectiveness (Phase 2)Study completedNCT02532179
What this trial is testing

Subcutaneous Immunotherapy for Mouse in Adults

Who this might be right for
AsthmaPerennial Allergic Rhinitis
National Institute of Allergy and Infectious Diseases (NIAID) 12
Early research (Phase 1)Looking for participantsNCT07148050
What this trial is testing

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

Who this might be right for
Solid Tumor (Excluding CNS)Liver Cell CarcinomaMalignant Rhabdoid Tumor+7 more
Seattle Children's Hospital 21
Early research (Phase 1)Study completedNCT00431210
What this trial is testing

Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Dana-Farber Cancer Institute 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT04580771
What this trial is testing

A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial

Who this might be right for
Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise SpecifiedStage IB3 Cervical Cancer FIGO 2018Stage II Cervical Cancer FIGO 2018+11 more
M.D. Anderson Cancer Center 22
Early research (Phase 1)Study completedNCT00112216
What this trial is testing

Immunotherapy of Melanoma Patients

Who this might be right for
Melanoma
Centre Hospitalier Universitaire Vaudois 9
Not applicableUnknownNCT05754983
What this trial is testing

Risk Factors and Long-term Impact of ICIs

Who this might be right for
Malignant Neoplasm
First Affiliated Hospital Xi'an Jiaotong University 1,000
Testing effectiveness (Phase 2)UnknownNCT03579654
What this trial is testing

Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance

Who this might be right for
Prostate Cancer
OncBioMune Pharmaceuticals 120
Next Page